Evidence map›Paper›PMID 37442615›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2023

Hope or hype? Clinicians' dilemma in the era of ever-expanding antigens in membranous nephropathy.

Marco Bonilla, Mohamed Hassanein, Tiffany Caza, Kenar D Jhaveri

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Marco BonillaSection of Nephrology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Mohamed HassaneinDivision of Nephrology and Hypertension, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Tiffany CazaArkana Laboratories, Little Rock, AR, USA.
Kenar D JhaveriDepartment of Medicine, Glomerular Center at Northwell Health, Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.ORCID 0000-0003-1578-0524
Arkana Laboratories · USNorthwell Health · USUniversity of Chicago · USUniversity of Mississippi Medical Center · US

Funding

Development of a Precision Medicine-based Diagnostic Tool for Membranous NephropathyR44DK130702 · NIDDK · NEPHROPATHOLOGY ASSOCIATES · PI LARSEN, CHRISTOPHER P, STOREY, AARON JOSEPH · 2022 to 2023
$1.9M
Development of specific peptide reagents for serologic monitoring of Exostosin autoantibodies in membranous lupus nephritisR43AR081720 · NIAMS · NEPHROPATHOLOGY ASSOCIATES · PI LARSEN, CHRISTOPHER P · 2022 to 2022
$259k
NIAMS NIH HHS R43 AR081720NIDDK NIH HHS R44 DK130702
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Glomerulonephritis, MembranousAutoantibodiesHumansKidney GlomerulusReceptors, Phospholipase A2AutoantibodiesReceptors, Phospholipase A2

Identifiers

PMID37442615
PMCPMC13396137
OpenAlexW4384129305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.